LIDDS Competitors and Similar CompaniesClear all
LIDDS's competitors and similar companies include Shanghai Junshi Biosciences and Kyowa Kirin.
 Shanghai Junshi Biosciences Shanghai Junshi Biosciences (上海君實生物醫藥科技) is a biopharmaceutical company focused on the treatment of cancer, autoimmune, and metabolic diseases. |  Kyowa Kirin Kyowa Kirin (formerly Kyowa Hakko Kirin) is a pharmaceutical company focused on the areas of oncology, nephrology, immunology, and the central nervous system. | ||
Founding Date | Founding Date 2015 | Founding Date 2012 | Founding Date 2008 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Uppsala, SE HQ | Locations Shanghai, CN HQ | |
Employees | Employees 1 | Employees 2,578 | Employees 5,669 |
Valuation ($) | Valuation ($) 1.5 m | Valuation ($) N/A | Valuation ($) 8.8 b |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) ¥2.4b (FY, 2025) | Revenue (est.) ¥496.8b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods ¥466.5m (FY, 2025) | Cost of goods ¥114.3b (FY, 2025) |
Gross profit | Gross profit kr977k (FY, 2024) | Gross profit ¥2b (FY, 2025) | Gross profit ¥383.4b (FY, 2025) |
Net income | Net income (kr5.9m) (FY, 2024) | Net income (¥1b) (FY, 2025) | Net income ¥67b (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
Shanghai Junshi Biosciences
HQ
Shanghai, CN
Employees
2,578
Shanghai Junshi Biosciences (上海君實生物醫藥科技) is a biopharmaceutical company focused on the treatment of cancer, autoimmune, and metabolic diseases.
View companyKyowa Kirin
HQ
Tokyo, JP
Employees
5,669
Kyowa Kirin (formerly Kyowa Hakko Kirin) is a pharmaceutical company focused on the areas of oncology, nephrology, immunology, and the central nervous system.
View company